Young-Joon Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Young-Joon Lee has a total of 182 co-authors. Here are the top co-authors by number of shared publications:
Sang-Ho Jeong
Department of Surgery, Gyeongsang National University, Jinju, Korea
18 shared publicationsChi-Young Jeong
Department of Surgery, College of Medicine, Gyeongsang National University, Jinju, South Korea
16 shared publicationsEun-Jung Jung
Department of Surgery, College of Medicine, Gyeongsang National University, Jinju, South Korea
16 shared publicationsWoo-Song Ha
Department of Surgery, Gyeongsang National University Hospital, Gyeongsang National University Postgraduate School of Medicine, 79 Gangnam-ro, Jinju, 52727, Republic of Korea
14 shared publicationsYoung-Tae Ju
Department of Surgery, College of Medicine, Gyeongsang National University, Jinju, South Korea
14 shared publications- Ji-Ho Park
Division of Gastrointestinal Surgery, Department of Surgery, Gyeongsang National University College of Medicine, Jinju, Korea
13 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 110 (5) , 331-346
WWP2 ubiquitin ligase promotes colorectal cancer progression by targeting p53 for degradation: an experimental study
Colorectal cancer (CRC) remains a leading cause of cancer-related mortality, necessitating the identification of novel therapeutic targets. The E3 ubiquitin ligase WW domain-containing E3 ubiquitin protein ligase 2 (WWP2) has been implicated in various cancers, yet its specific role and underlying molecular mechanisms in CRC are poorly understood. This study aimed to investigate the functional role of WWP2 in CRC progression and to elucidate its regulatory mechanisms. WWP2 expression was evaluated in CRC patient tissues and cell lines using immunohistochemistry, quantitative real-time polymerase chain reaction, and western blotting. The biological functions of WWP2 were assessed using in vitro assays for cell proliferation, migration, and invasion following adenovirus-mediated overexpression. The molecular mechanism was investigated by analyzing the protein expression levels of p53 and its downstream target, p21, via western blot. An in vivo xenograft mouse model was used to confirm the oncogenic role of WWP2. WWP2 expression was significantly upregulated in CRC tissues. Overexpression of WWP2 promoted CRC cell proliferation, migration, and invasion. Mechanistically, increased WWP2 expression led to a marked reduction in the protein levels of the tumor suppressor p53. Consequently, the expression of the p53 downstream target, the cell cycle inhibitor p21, was also suppressed. In the xenograft model, WWP2 overexpression significantly enhanced tumor growth. Our findings demonstrate that WWP2 functions as an oncogene in CRC. It promotes cancer progression by destabilizing the tumor suppressor p53 and downregulating p21. This study highlights the WWP2-p53-p21 axis as a potential novel therapeutic target for CRC.
- 1 January 2026
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 110 (5) , 331-346
Open AccessWWP2 ubiquitin ligase promotes colorectal cancer progression by targeting p53 for degradation: an experimental study
Colorectal cancer (CRC) remains a leading cause of cancer-related mortality, necessitating the identification of novel therapeutic targets. The E3 ubiquitin ligase WW domain-containing E3 ubiquitin protein ligase 2 (WWP2) has been implicated in various cancers, yet its specific role and underlying molecular mechanisms in CRC are poorly understood. This study aimed to investigate the functional role of WWP2 in CRC progression and to elucidate its regulatory mechanisms. WWP2 expression was evaluated in CRC patient tissues and cell lines using immunohistochemistry, quantitative real-time polymerase chain reaction, and western blotting. The biological functions of WWP2 were assessed using in vitro assays for cell proliferation, migration, and invasion following adenovirus-mediated overexpression. The molecular mechanism was investigated by analyzing the protein expression levels of p53 and its downstream target, p21, via western blot. An in vivo xenograft mouse model was used to confirm the oncogenic role of WWP2. WWP2 expression was significantly upregulated in CRC tissues. Overexpression of WWP2 promoted CRC cell proliferation, migration, and invasion. Mechanistically, increased WWP2 expression led to a marked reduction in the protein levels of the tumor suppressor p53. Consequently, the expression of the p53 downstream target, the cell cycle inhibitor p21, was also suppressed. In the xenograft model, WWP2 overexpression significantly enhanced tumor growth. Our findings demonstrate that WWP2 functions as an oncogene in CRC. It promotes cancer progression by destabilizing the tumor suppressor p53 and downregulating p21. This study highlights the WWP2-p53-p21 axis as a potential novel therapeutic target for CRC.
- Open Access
- 15 December 2025
- Published by The Korean Society of Endo-Laparoscopic & Robotic Surgery in Journal of Minimally Invasive Surgery
- Vol. 28 (4) , 184-192
Current status of treatment for esophagojejunostomy leakage after total gastrectomy in patients with gastric cancer: a multicenter retrospective study in Korea
Min-Chan Kim, Mi Ran Jung, Jeong Ju Noh, Sunghwa Kang, Jae Hun Chung, Ji-Ho Park, Tae-Han Kim, Jae Kyun Park, Yoonhong Kim, Sang Hyuk Seo, Sung Eun Kim, Oh Kyung Kwon, Ji Yeon Park, Ki Bum Park, Sun-Hwi Hwang, SI-Hak Lee, Young-Joon Lee, Sang-Ho Jeong, Tae-Yong Jeon, Dae Hwan Kim, Chang In Choi, Ki Young Yoon, Kyung Won Seo, Ki Hyun Kim, Sang Hoon Oh, Kwang Hee Kim. Journal of Minimally Invasive Surgery 2025;28:184-92. https://doi.org/10.7602/jmis.2025.28.4.184
- 15 December 2025
- Published by The Korean Society of Endo-Laparoscopic & Robotic Surgery in Journal of Minimally Invasive Surgery
- Vol. 28 (4) , 184-192
Open AccessCurrent status of treatment for esophagojejunostomy leakage after total gastrectomy in patients with gastric cancer: a multicenter retrospective study in Korea
Min-Chan Kim, Mi Ran Jung, Jeong Ju Noh, Sunghwa Kang, Jae Hun Chung, Ji-Ho Park, Tae-Han Kim, Jae Kyun Park, Yoonhong Kim, Sang Hyuk Seo, Sung Eun Kim, Oh Kyung Kwon, Ji Yeon Park, Ki Bum Park, Sun-Hwi Hwang, SI-Hak Lee, Young-Joon Lee, Sang-Ho Jeong, Tae-Yong Jeon, Dae Hwan Kim, Chang In Choi, Ki Young Yoon, Kyung Won Seo, Ki Hyun Kim, Sang Hoon Oh, Kwang Hee Kim. Journal of Minimally Invasive Surgery 2025;28:184-92. https://doi.org/10.7602/jmis.2025.28.4.184
- Open Access
- 12 December 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (50) , e46469
Validation of a dietary intake questionnaire through nutritional markers and clinical outcomes in patients with gastric cancer following gastrectomy
This study aimed to validate a semiquantitative, patient-reported dietary questionnaire by assessing its correlation with nutritional screening tools and clinical outcomes over time. In this prospective study, a simplified questionnaire was developed to assess patients’ diet volume (DV) intake relative to their preoperative baseline, along with meal and snack frequency. The questionnaire was administered preoperatively and at 1, 2, 3, 6, and 12 months after surgery. At each timepoint, a clinical nutritionist provided dietary counseling, and caloric intake per meal was evaluated. Nutritional assessments included body weight, laboratory markers, body composition (bioelectrical impedance spectroscopy), and nutritional screening tools (nutritional risk screening [NRS]-2002 and patient-generated subjective global assessment [PG-SGA]). Correlation analyses were performed between DV and nutritional parameters. Among the 341 patients, DV significantly decreased to 39.7% at 1 month and recovered to 74.8% by 12 months after surgery ( P < .001). Snack frequency increased significantly at all postoperative timepoints, whereas meal frequency showed a transient increase only at 1 month. The estimated caloric intake initially decreased but then normalized by the 6th month. The NRS and PG-SGA scores peaked at 1 month and improved over time. DV was positively correlated with estimated caloric intake ( r = 0.299–0.599, P < .05) and negatively correlated with weight loss ( r = –0.119 to–0.301, P < .05). The strongest negative correlations were observed at 3 months, with NRS ( r = –0.28) and PG-SGA ( r = –0.46) scores. No significant correlations were found with white blood cell count or hemoglobin levels. The dietary questionnaire demonstrated a strong correlation with nutritional indicators and validated screening tools, supporting its potential utility in identifying nutritional risk, tracking recovery, and guiding interventions in postoperative patients with gastric cancer.
- 12 December 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (50) , e46469
Open AccessValidation of a dietary intake questionnaire through nutritional markers and clinical outcomes in patients with gastric cancer following gastrectomy
This study aimed to validate a semiquantitative, patient-reported dietary questionnaire by assessing its correlation with nutritional screening tools and clinical outcomes over time. In this prospective study, a simplified questionnaire was developed to assess patients’ diet volume (DV) intake relative to their preoperative baseline, along with meal and snack frequency. The questionnaire was administered preoperatively and at 1, 2, 3, 6, and 12 months after surgery. At each timepoint, a clinical nutritionist provided dietary counseling, and caloric intake per meal was evaluated. Nutritional assessments included body weight, laboratory markers, body composition (bioelectrical impedance spectroscopy), and nutritional screening tools (nutritional risk screening [NRS]-2002 and patient-generated subjective global assessment [PG-SGA]). Correlation analyses were performed between DV and nutritional parameters. Among the 341 patients, DV significantly decreased to 39.7% at 1 month and recovered to 74.8% by 12 months after surgery ( P < .001). Snack frequency increased significantly at all postoperative timepoints, whereas meal frequency showed a transient increase only at 1 month. The estimated caloric intake initially decreased but then normalized by the 6th month. The NRS and PG-SGA scores peaked at 1 month and improved over time. DV was positively correlated with estimated caloric intake ( r = 0.299–0.599, P < .05) and negatively correlated with weight loss ( r = –0.119 to–0.301, P < .05). The strongest negative correlations were observed at 3 months, with NRS ( r = –0.28) and PG-SGA ( r = –0.46) scores. No significant correlations were found with white blood cell count or hemoglobin levels. The dietary questionnaire demonstrated a strong correlation with nutritional indicators and validated screening tools, supporting its potential utility in identifying nutritional risk, tracking recovery, and guiding interventions in postoperative patients with gastric cancer.
- Open Access
- 1 December 2025
- Published by Korean Society of Clinical Oncology in Korean Journal of Clinical Oncology
- Vol. 21 (3) , 121-129
Comparative analysis of endoscopic and nutritional outcomes following distal gastrectomy: Roux-en-Y, uncut Roux-en-Y, and Billroth II with Braun anastomosis
Purpose: This study aimed to compare clinical, nutritional, and endoscopic outcomes among Roux-en-Y (RY), uncut Roux-en-Y (uRY), and Billroth II with Braun anastomosis (BB) reconstruction methods in gastric cancer patients after distal gastrectomy.Methods: This retrospective study analyzed gastric cancer patients who underwent laparoscopic distal gastrectomy between January 2018 and December 2022, categorized into RY, uRY, and BB. Demographic, pathological, clinical, nutritional, and endoscopic data were collected over 24 months. Endoscopic outcomes were assessed using the RGB scoring system, evaluating residual food, gastritis, and bile reflux. Delayed gastric emptying was defined by clinical and imaging criteria. Multivariable linear regression was performed to identify relevant factors associated with 24 months RGB scores and mixed linear model was applied to assess the time interaction.Results: A total of 221 patients were included (70 RY, 75 uRY, 76 BB). Baseline characteristics, perioperative and nutritional outcomes were comparable among groups. The uRY group showed less weight loss at 3 months (5.9%, P<0.05) but did not differ in other studied periods. The RY group had the lowest RGB scores at all time points, while BB showed the highest and progressively worsening scores. Regression model showed that BB and uRY was related to increase 24 month RGB score. BB showed increased RGB score while RY was stable in time and uRY showed intermediate change in the mixed linear model (P<0.05).Conclusion: The nutritional clinical outcomes were comparable between the reconstructions. RY reconstruction demonstrated favorable endoscopic outcomes, while BB was associated with higher RGB scores in time.
- 1 December 2025
- Published by Korean Society of Clinical Oncology in Korean Journal of Clinical Oncology
- Vol. 21 (3) , 121-129
Open AccessComparative analysis of endoscopic and nutritional outcomes following distal gastrectomy: Roux-en-Y, uncut Roux-en-Y, and Billroth II with Braun anastomosis
Purpose: This study aimed to compare clinical, nutritional, and endoscopic outcomes among Roux-en-Y (RY), uncut Roux-en-Y (uRY), and Billroth II with Braun anastomosis (BB) reconstruction methods in gastric cancer patients after distal gastrectomy.Methods: This retrospective study analyzed gastric cancer patients who underwent laparoscopic distal gastrectomy between January 2018 and December 2022, categorized into RY, uRY, and BB. Demographic, pathological, clinical, nutritional, and endoscopic data were collected over 24 months. Endoscopic outcomes were assessed using the RGB scoring system, evaluating residual food, gastritis, and bile reflux. Delayed gastric emptying was defined by clinical and imaging criteria. Multivariable linear regression was performed to identify relevant factors associated with 24 months RGB scores and mixed linear model was applied to assess the time interaction.Results: A total of 221 patients were included (70 RY, 75 uRY, 76 BB). Baseline characteristics, perioperative and nutritional outcomes were comparable among groups. The uRY group showed less weight loss at 3 months (5.9%, P<0.05) but did not differ in other studied periods. The RY group had the lowest RGB scores at all time points, while BB showed the highest and progressively worsening scores. Regression model showed that BB and uRY was related to increase 24 month RGB score. BB showed increased RGB score while RY was stable in time and uRY showed intermediate change in the mixed linear model (P<0.05).Conclusion: The nutritional clinical outcomes were comparable between the reconstructions. RY reconstruction demonstrated favorable endoscopic outcomes, while BB was associated with higher RGB scores in time.
- Open Access
- 15 August 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (33) , e43837
Sex and the extent of gastrectomy are important factors for postoperative diet recovery in gastrectomy patients
The aim of the present study was analyzing various indicators related to dietary intake and the risk factors for reduced dietary intake after gastrectomy. Through this, we aim to identify the factors affecting the reduction in dietary intake among patients after gastrectomy and, consequently, propose strategies to promote dietary recovery. Data from 206 patients at a single center were retrospectively analyzed. Dietary habits and nutritional status were compared using survey data. Univariate and multivariate analyses were performed to identify factors associated with dietary intake reduction. Univariate analysis revealed that patient sex, extent of gastrectomy, pulmonary disease, and chronic liver disease significantly influenced postoperative dietary intake reduction ( P < .05). However, multivariate analysis identified that sex and extent of gastrectomy were significantly different ( P < .05). In particular, female patients who underwent total gastrectomy exhibited a greater relative risk (relative risk = 7.4) than male patients who underwent distal gastrectomy. Female sex and total gastrectomy are factors that influence postoperative dietary intake reduction. Therefore, when educating female TG patients about postoperative diet, it is important to increase diet frequency rather than quantity of postoperative diet.
- 15 August 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (33) , e43837
Open AccessSex and the extent of gastrectomy are important factors for postoperative diet recovery in gastrectomy patients
The aim of the present study was analyzing various indicators related to dietary intake and the risk factors for reduced dietary intake after gastrectomy. Through this, we aim to identify the factors affecting the reduction in dietary intake among patients after gastrectomy and, consequently, propose strategies to promote dietary recovery. Data from 206 patients at a single center were retrospectively analyzed. Dietary habits and nutritional status were compared using survey data. Univariate and multivariate analyses were performed to identify factors associated with dietary intake reduction. Univariate analysis revealed that patient sex, extent of gastrectomy, pulmonary disease, and chronic liver disease significantly influenced postoperative dietary intake reduction ( P < .05). However, multivariate analysis identified that sex and extent of gastrectomy were significantly different ( P < .05). In particular, female patients who underwent total gastrectomy exhibited a greater relative risk (relative risk = 7.4) than male patients who underwent distal gastrectomy. Female sex and total gastrectomy are factors that influence postoperative dietary intake reduction. Therefore, when educating female TG patients about postoperative diet, it is important to increase diet frequency rather than quantity of postoperative diet.
- Open Access
Risk Factors for Long-Term Delayed Gastric Emptying and Its Impact on the Quality of Life After Laparoscopic Pylorus-Preserving Gastrectomy in Patients with Gastric Cancer: Secondary Analysis of the Prospective Multicenter Trial KLASS-04
Background/Objectives: Delayed gastric emptying (DGE) is a well-known complication of laparoscopic pylorus-preserving gastrectomy (LPPG). Patients who underwent LPPG in the KLASS-04 trial, which was a multicenter prospective randomized control trial comparing LPPG and laparoscopic distal gastrectomy (LDG), showed an unneglectable incidence of long-term DGE compared to patients who underwent LDG. This study aimed to identify the multifactorial risk factors associated with DGE and to analyze the quality of life (QoL) of patients with DGE following LPPG. Methods: DGE was defined as “nearly normal diet residue” at least once in the endoscopic follow-up at 1, 2, and 3 years after the surgery. Clinicopathological features, surgical outcomes, and QoL were compared between the DGE and non-DGE groups. Results: DGE was observed in 21/124 patients (16.3%) who underwent LPPG. Patients without previous abdominal surgery had a higher incidence of DGE in the univariate (32% vs. 4.8%, p = 0.011) and logistic regression analyses (odds ratio: 0.106, 95% confidence interval: 0.014–0.824, p = 0.032). Patients with DGE reported more symptoms of nausea and vomiting (p = 0.004), constipation (p = 0.04), and a dry mouth (p = 0.005). Conclusions: Despite the strict protocol used to avoid well-known risk factors for DGE, such as damage to the hepatic branch of the vagus nerve, infrapyloric artery and vein, and short antral cuff, the LPPG group of the KLASS-04 trial exhibited a considerable incidence of DGE. No clinicopathological or surgical factors, other than the absence of a previous surgical history, were identified as multifactorial risk factors for DGE. However, DGE had a negative impact on the QoL of patients.
Open AccessRisk Factors for Long-Term Delayed Gastric Emptying and Its Impact on the Quality of Life After Laparoscopic Pylorus-Preserving Gastrectomy in Patients with Gastric Cancer: Secondary Analysis of the Prospective Multicenter Trial KLASS-04
Background/Objectives: Delayed gastric emptying (DGE) is a well-known complication of laparoscopic pylorus-preserving gastrectomy (LPPG). Patients who underwent LPPG in the KLASS-04 trial, which was a multicenter prospective randomized control trial comparing LPPG and laparoscopic distal gastrectomy (LDG), showed an unneglectable incidence of long-term DGE compared to patients who underwent LDG. This study aimed to identify the multifactorial risk factors associated with DGE and to analyze the quality of life (QoL) of patients with DGE following LPPG. Methods: DGE was defined as “nearly normal diet residue” at least once in the endoscopic follow-up at 1, 2, and 3 years after the surgery. Clinicopathological features, surgical outcomes, and QoL were compared between the DGE and non-DGE groups. Results: DGE was observed in 21/124 patients (16.3%) who underwent LPPG. Patients without previous abdominal surgery had a higher incidence of DGE in the univariate (32% vs. 4.8%, p = 0.011) and logistic regression analyses (odds ratio: 0.106, 95% confidence interval: 0.014–0.824, p = 0.032). Patients with DGE reported more symptoms of nausea and vomiting (p = 0.004), constipation (p = 0.04), and a dry mouth (p = 0.005). Conclusions: Despite the strict protocol used to avoid well-known risk factors for DGE, such as damage to the hepatic branch of the vagus nerve, infrapyloric artery and vein, and short antral cuff, the LPPG group of the KLASS-04 trial exhibited a considerable incidence of DGE. No clinicopathological or surgical factors, other than the absence of a previous surgical history, were identified as multifactorial risk factors for DGE. However, DGE had a negative impact on the QoL of patients.
- Open Access
- 1 January 2025
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 109 (2) , 98-104
Impact of smoking and age on long-term recurrence after laparoscopic primary closure for duodenal ulcer perforation: a 5-year observational study
Kim TH, et al. Ann Surg Treat Res. 2025 Aug;109(2):98-104. https://doi.org/10.4174/astr.2025.109.2.98
- 1 January 2025
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 109 (2) , 98-104
Open AccessImpact of smoking and age on long-term recurrence after laparoscopic primary closure for duodenal ulcer perforation: a 5-year observational study
Kim TH, et al. Ann Surg Treat Res. 2025 Aug;109(2):98-104. https://doi.org/10.4174/astr.2025.109.2.98
- Open Access
- 1 January 2025
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 108 (6) , 374-389
MicroRNA-18b regulates cell cycle progression in papillary thyroid carcinoma by targeting CDK2: an in vitro experimental study
Kim JY, et al. Ann Surg Treat Res. 2025 Jun;108(6):374-389. https://doi.org/10.4174/astr.2025.108.6.374
- 1 January 2025
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 108 (6) , 374-389
Open AccessMicroRNA-18b regulates cell cycle progression in papillary thyroid carcinoma by targeting CDK2: an in vitro experimental study
Kim JY, et al. Ann Surg Treat Res. 2025 Jun;108(6):374-389. https://doi.org/10.4174/astr.2025.108.6.374
- 25 January 2024
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 281 (2) , 296-303
Clinical Efficacy of Laparoscopic Sentinel Node Navigation Surgery for Stomach Preservation in Patients With Early Gastric Cancer
Objective: This study aimed to compare laparoscopic standard gastrectomy (LSG) and laparoscopic sentinel node navigation surgery (LSNNS) for early gastric cancer (EGC) in terms of 5-year long-term oncologic outcomes. Background: The oncological safety of LSNNS for EGC has not been confirmed. Three-year disease-free survival (DFS), which is the primary endpoint of phase III multicenter randomized controlled clinical trial [SEntinel Node ORIented Tailored Approach (SENORITA) trial], did not show the noninferiority of LSNNS relative to LSG. Methods: The SENORITA trial, a multicenter randomized clinical trial, was designed to show that LSNNS is noninferior to LSG in terms of 3-year DFS. In the present study, we collected 5-year follow-up data from 527 patients recruited in the SENORITA trial as the full analysis set. DFS, overall survival (OS), disease-specific survival (DSS), and recurrence patterns were evaluated using the full analysis set of both LSG (n=269) and LSNNS (n=258). Results: The 5-year DFS was not significantly different between the LSG and LSNNS groups ( P =0.0561). During the 5-year follow-up, gastric cancer–related events, such as metachronous cancer, were more frequent in the LSNNS group than in the LSG group. However, 10 recurrent cancers in the remnant stomach of both groups were curatively resected by additional gastrectomy and 1 by additional endoscopic resection. Two of the 198 patients who underwent local resection for stomach preservation based on the LSNNS results developed distant metastasis. However, there was no statistically significant difference in the 5-year OS and DSS ( P =0.7403 and P =0.9586, respectively) between the two groups. Conclusions: The 5-year DFS, DSS, and OS did not differ significantly between the two groups. Considering the benefits of LSNNS on postoperative quality of life, LSNNS could be recommended as an alternative treatment option for EGC.
- 25 January 2024
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 281 (2) , 296-303
Clinical Efficacy of Laparoscopic Sentinel Node Navigation Surgery for Stomach Preservation in Patients With Early Gastric Cancer
Objective: This study aimed to compare laparoscopic standard gastrectomy (LSG) and laparoscopic sentinel node navigation surgery (LSNNS) for early gastric cancer (EGC) in terms of 5-year long-term oncologic outcomes. Background: The oncological safety of LSNNS for EGC has not been confirmed. Three-year disease-free survival (DFS), which is the primary endpoint of phase III multicenter randomized controlled clinical trial [SEntinel Node ORIented Tailored Approach (SENORITA) trial], did not show the noninferiority of LSNNS relative to LSG. Methods: The SENORITA trial, a multicenter randomized clinical trial, was designed to show that LSNNS is noninferior to LSG in terms of 3-year DFS. In the present study, we collected 5-year follow-up data from 527 patients recruited in the SENORITA trial as the full analysis set. DFS, overall survival (OS), disease-specific survival (DSS), and recurrence patterns were evaluated using the full analysis set of both LSG (n=269) and LSNNS (n=258). Results: The 5-year DFS was not significantly different between the LSG and LSNNS groups ( P =0.0561). During the 5-year follow-up, gastric cancer–related events, such as metachronous cancer, were more frequent in the LSNNS group than in the LSG group. However, 10 recurrent cancers in the remnant stomach of both groups were curatively resected by additional gastrectomy and 1 by additional endoscopic resection. Two of the 198 patients who underwent local resection for stomach preservation based on the LSNNS results developed distant metastasis. However, there was no statistically significant difference in the 5-year OS and DSS ( P =0.7403 and P =0.9586, respectively) between the two groups. Conclusions: The 5-year DFS, DSS, and OS did not differ significantly between the two groups. Considering the benefits of LSNNS on postoperative quality of life, LSNNS could be recommended as an alternative treatment option for EGC.
- Open Access
- 1 December 2023
- Published by Korean Society of Clinical Oncology in Korean Journal of Clinical Oncology
- Vol. 19 (2) , 52-59
The prognostic impact of body mass index in breast cancer according to tumor subtype
Purpose: Several studies demonstrated that obesity and underweight were negatively associated with outcomes of breast cancer. However, the results are still controversial, and the impact of body mass index (BMI) on distant metastasis-free survival (MFS), which might directly affect mortality, was less well evaluated. Our study aimed to verify the prognostic effect of BMI in breast cancer.Methods: A retrospective analysis of 504 patients with stage I-III breast cancer who underwent surgery from January 2005 to December 2013 was performed. The patients were divided into three groups according to preoperative BMI: underweight <18.5 kg/m2, normal weight 18.5–24.9 kg/m2, and overweight ≥25 kg/m2. The association between body weight status and breast cancer recurrence was analyzed. Subgroup analysis by tumor subtype according to receptor status was also performed.Results: The median follow-up period was 88 months. For disease recurrence, histologic grade and human epidermal growth factor receptor 2 (HER2)-positivity were independent prognostic factors in multivariate analysis. Stage, histologic grade, HER2-positivity, and BMI status were independent prognostic factors for distant metastasis. In survival analysis, overweight and underweight were significant predisposing factors for MFS, but not for disease-free survival (DFS). In the estrogen receptor (ER)-positive group, overweight and underweight patients had significantly worse DFS and MFS than normal weight patients. In the ER-negative or HER2-positive group, BMI status had no significant association with DFS and MFS.Conclusion: The prognostic role of BMI on the survival outcomes of patients with breast cancer was different by tumor subtype. In ER-positive patients, overweight and underweight statuses had a negative prognostic effect on DFS and MFS, respectively.
- 1 December 2023
- Published by Korean Society of Clinical Oncology in Korean Journal of Clinical Oncology
- Vol. 19 (2) , 52-59
Open AccessThe prognostic impact of body mass index in breast cancer according to tumor subtype
Purpose: Several studies demonstrated that obesity and underweight were negatively associated with outcomes of breast cancer. However, the results are still controversial, and the impact of body mass index (BMI) on distant metastasis-free survival (MFS), which might directly affect mortality, was less well evaluated. Our study aimed to verify the prognostic effect of BMI in breast cancer.Methods: A retrospective analysis of 504 patients with stage I-III breast cancer who underwent surgery from January 2005 to December 2013 was performed. The patients were divided into three groups according to preoperative BMI: underweight <18.5 kg/m2, normal weight 18.5–24.9 kg/m2, and overweight ≥25 kg/m2. The association between body weight status and breast cancer recurrence was analyzed. Subgroup analysis by tumor subtype according to receptor status was also performed.Results: The median follow-up period was 88 months. For disease recurrence, histologic grade and human epidermal growth factor receptor 2 (HER2)-positivity were independent prognostic factors in multivariate analysis. Stage, histologic grade, HER2-positivity, and BMI status were independent prognostic factors for distant metastasis. In survival analysis, overweight and underweight were significant predisposing factors for MFS, but not for disease-free survival (DFS). In the estrogen receptor (ER)-positive group, overweight and underweight patients had significantly worse DFS and MFS than normal weight patients. In the ER-negative or HER2-positive group, BMI status had no significant association with DFS and MFS.Conclusion: The prognostic role of BMI on the survival outcomes of patients with breast cancer was different by tumor subtype. In ER-positive patients, overweight and underweight statuses had a negative prognostic effect on DFS and MFS, respectively.